Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising hepatitis E incidence
3.2.1.2 Advancement in diagnostic technologies
3.2.1.3 Rising awareness and screening programs
3.2.2 Industry pitfalls & challenges
3.2.2.1 Limited availability in developing regions
3.2.2.2 Stringent regulatory scenario
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technology landscape
3.5.1 Core technologies
3.5.2 Adjacent technologies
3.6 Future market trends
3.7 Gap analysis
3.8 Porter’s analysis
3.9 PESTLE analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Test Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 ELISA HEV IgM test
5.3 ELISA HEV IgG test
5.4 Rapid diagnostics test
5.5 Polymerase chain reaction (PCR)
Chapter 6 Market Estimates and Forecast, By Sample Type, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Blood
6.3 Stool
Chapter 7 Market Estimates and Forecast, By End-use, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Hospitals
7.3 Diagnostic laboratories
7.4 Blood banks
7.5 Other end-users
Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Netherlands
8.3.7 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Rest of Latin America
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 altona Diagnostics GmbH
9.2 CTK Biotech, Inc.
9.3 Dia.Pro Diagnostic Bioprobes s.r.l
9.4 DiaSorin S.p.A.
9.5 ELITechGroup ( Bruker company)
9.6 F. Hoffmann-La Roche Ltd
9.7 Fortress Diagnostics
9.8 Genscript Biotech Corporation
9.9 Guangzhou Wondfo Biotech Co., Ltd.
9.10 Medsource Ozone Biomedicals Pvt. Ltd.
9.11 MIKROGEN GmbH
9.12 MP Biomedicals
9.13 Primer Design
9.14 Wantai BioPharm
